Genetics and molecular pathology of Stargardt-like macular degeneration

Progress in Retinal and Eye Research

Volumn 29, Issue 3, 2010, Pages 191-207

  Vasireddy, Vidyullatha ^a   Wong, Paul ^b   Ayyagari, Radha ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; Dominant negative effect; ELOVL4; Fatty acids; Protein accumulation; STGD3

Indexed keywords

ELONGATION OF VERY LONG CHAIN FATTY ACID 4; LIPOFUSCIN; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID;

AUTOSOMAL DOMINANT DISORDER; BIOACCUMULATION; CHROMOSOME 6; ENVIRONMENTAL FACTOR; EYE FUNDUS; FATTY ACID METABOLISM; FRAMESHIFT MUTATION; GENE DELETION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; HAPLOTYPE; HOMOLOGOUS RECOMBINATION; HUMAN; LIPID METABOLISM; NONHUMAN; PATHOGENESIS; PHENOTYPE; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN TRANSPORT; RETINA; REVIEW; RNA TRANSLATION; STARGARDT DISEASE; VISUAL ACUITY; VISUAL IMPAIRMENT;

ANIMALS; CHROMOSOMES, HUMAN, PAIR 6; EYE PROTEINS; FATTY ACIDS; HUMANS; MACULAR DEGENERATION; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MUTATION; PATHOLOGY, MOLECULAR;

EID: 77951204243     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2010.01.001     Document Type: Review

References (119)

1. Aaberg T.M. Stargardt's disease and fundus flavimaculatus: evaluation of morphologic progression and intrafamilial co-existence. Trans. Am. Ophthalmol. Soc. 1986, 84:453-487.
2. Agbaga M.P., Brush R.S., Mandal M.N., Henry K., Elliott M.H., Anderson R.E. Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:12843-12848.
3. Agbaga M.-P., Mandal M.A., Brush R.S., Zheng L., Henry K., Elliott M.H., Vasireddy V., Petrukhin K., Ayyagari R., Anderson R.E. Quantitative Analysis of ELOVL4 Protein and Fatty Acid Products in Knock-out and Knock-in Mouse Tissues 2009, The Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, USA.
4. Allikmets R., Shroyer N.F., Singh N., Seddon J.M., Lewis R.A., Bernstein P.S., Peiffer A., Zabriskie N.A., Li Y., Hutchinson A., Dean M., Lupski J.R., Leppert M. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997, 277:1805-1807.
5. Ambasudhan R., Wang X., Jablonski M.M., Thompson D.A., Lagali P.S., Wong P.W., Sieving P.A., Ayyagari R. Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein. Genomics 2004, 83:615-625.
6. Ambati J., Anand A., Fernandez S., Sakurai E., Lynn B.C., Kuziel W.A., Rollins B.J., Ambati B.K. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat. Med. 2003, 9:1390-1397.
7. Anderson R.E., Benolken R.M., Dudley P.A., Landis D.J., Wheeler T.G. Proceedings: polyunsaturated fatty acids of photoreceptor membranes. Exp. Eye Res. 1974, 18:205-213.
8. Aveldano M.I. Phospholipid species containing long and very long polyenoic fatty acids remain with rhodopsin after hexane extraction of photoreceptor membranes. Biochemistry 1988, 27:1229-1239.
9. Aveldano M.I., Bazan N.G. Free fatty acids, diacyl- and triacylglycerols and total phospholipids in vertebrate retina: comparison with brain, choroid and plasma. J. Neurochem. 1974, 23:1127-1135.
10. Aveldano M.I., Sprecher H. Very long chain (C24 to C36) polyenoic fatty acids of the n-3 and n-6 series in dipolyunsaturated phosphatidylcholines from bovine retina. J. Biol. Chem. 1987, 262:1180-1186.
11. Barthes A., Conrath J., Ridings B. J. Fr. Ophtalmol. 2005, 28:298-302.
12. Ben-Shabat S., Parish C.A., Hashimoto M., Liu J., Nakanishi K., Sparrow J.R. Fluorescent pigments of the retinal pigment epithelium and age-related macular degeneration. Bioorg. Med. Chem. Lett. 2001, 11:1533-1540.
13. Ben-Shabat S., Parish C.A., Vollmer H.R., Itagaki Y., Fishkin N., Nakanishi K., Sparrow J.R. Biosynthetic studies of A2E, a major fluorophore of retinal pigment epithelial lipofuscin. J. Biol. Chem. 2002, 277:7183-7190.
14. Bernstein P.S., Tammur J., Singh N., Hutchinson A., Dixon M., Pappas C.M., Zabriskie N.A., Zhang K., Petrukhin K., Leppert M., Allikmets R. Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene. Invest. Ophthalmol. Vis. Sci. 2001, 42:3331-3336.
15. Blacharski R. Fundus Flavimaculatus 1988, Raven Press, New York.
16. Bouwstra J., Pilgram G., Gooris G., Koerten H., Ponec M. New aspects of the skin barrier organization. Skin Pharmacol. Appl. Skin Physiol. 2001, 14(Suppl. 1):52-62.
17. Bressler N.M., Silva J.C., Bressler S.B., Fine S.L., Green W.R. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. 1994. Retina 2005, 25:130-142.
18. Bumcrot D., Manoharan M., Koteliansky V., Sah D.W. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat. Chem. Biol. 2006, 2:711-719.
19. Cameron D.J., Tong Z., Yang Z., Kaminoh J., Kamiyah S., Chen H., Zeng J., Chen Y., Luo L., Zhang K. Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival. Int. J. Biol. Sci. 2007, 3:111-119.
20. Cho E., Hankinson S.E., Willett W.C., Stampfer M.J., Spiegelman D., Speizer F.E., Rimm E.B., Seddon J.M. Prospective study of alcohol consumption and the risk of age-related macular degeneration. Arch. Ophthalmol. 2000, 118:681-688.
21. Cho E., Hung S., Willett W.C., Spiegelman D., Rimm E.B., Seddon J.M., Colditz G.A., Hankinson S.E. Prospective study of dietary fat and the risk of age-related macular degeneration. Am. J. Clin. Nutr. 2001, 73:209-218.
22. Chong E.W., Robman L.D., Simpson J.A., Hodge A.M., Aung K.Z., Dolphin T.K., English D.R., Giles G.G., Guymer R.H. Fat consumption and its association with age-related macular degeneration. Arch. Ophthalmol. 2009, 127:674-680.
23. Chua B., Flood V., Rochtchina E., Wang J.J., Smith W., Mitchell P. Dietary fatty acids and the 5-year incidence of age-related maculopathy. Arch. Ophthalmol. 2006, 124:981-986.
24. Cibis G.W., Morey M., Harris D.J. Dominantly inherited macular dystrophy with flecks (Stargardt). Arch. Ophthalmol. 1980, 98:1785-1789.
25. Cinti D.L., Cook L., Nagi M.N., Suneja S.K. The fatty acid chain elongation system of mammalian endoplasmic reticulum. Prog. Lipid Res. 1992, 31:1-51.
26. Clemons T.E., Milton R.C., Klein R., Seddon J.M., Ferris F.L. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 2005, 112:533-539.
27. Congdon N., O'Colmain B., Klaver C.C., Klein R., Munoz B., Friedman D.S., Kempen J., Taylor H.R., Mitchell P. Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol. 2004, 122:477-485.
28. Conley Y.P., Thalamuthu A., Jakobsdottir J., Weeks D.E., Mah T., Ferrell R.E., Gorin M.B. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum. Mol. Genet. 2005, 14:1991-2002.
29. Crabb J.W., Miyagi M., Gu X., Shadrach K., West K.A., Sakaguchi H., Kamei M., Hasan A., Yan L., Rayborn M.E., Salomon R.G., Hollyfield J.G. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:14682-14687.
30. De Jong P.T., Bergen A.A., Klaver C.C., Van Duijn C.M., Assink J.M. Age-related maculopathy: its genetic basis. Eye 2001, 15:396-400.
31. Donoso L.A., Edwards A.O., Frost A., Vrabec T., Stone E.M., Hageman G.S., Perski T. Autosomal dominant Stargardt-like macular dystrophy. Surv. Ophthalmol. 2001, 46:149-163.
32. Donoso L.A., Frost A.T., Stone E.M., Weleber R.G., MacDonald I.M., Hageman G.S., Cibis G.W., Ritter R., Edwards A.O. Autosomal dominant Stargardt-like macular dystrophy: founder effect and reassessment of genetic heterogeneity. Arch. Ophthalmol. 2001, 119:564-570.
33. Donoso A., Martens C.C. Quantum tunneling using entangled classical trajectories. Phys. Rev. Lett. 2001, 87:223202.
34. Eagle R.C., Lucier A.C., Bernardino V.B., Yanoff M. Retinal pigment epithelial abnormalities in fundus flavimaculatus: a light and electron microscopic study. Ophthalmology 1980, 87:1189-1200.
35. Edwards A.O., Donoso L.A., Ritter R. A novel gene for autosomal dominant Stargardt-like macular dystrophy with homology to the SUR4 protein family. Invest. Ophthalmol. Vis. Sci. 2001, 42:2652-2663.
36. Edwards A.O., Miedziak A., Vrabec T., Verhoeven J., Acott T.S., Weleber R.G., Donoso L.A. Autosomal dominant Stargardt-like macular dystrophy: I. Clinical characterization, longitudinal follow-up, and evidence for a common ancestry in families linked to chromosome 6q14. Am. J. Ophthalmol. 1999, 127:426-435.
37. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
38. Evans J.R. Risk factors for age-related macular degeneration. Prog. Retin. Eye Res. 2001, 20:227-253.
39. Furland N.E., Maldonado E.N., Aresti P.A., Aveldano M.I. Changes in lipids containing long- and very long-chain polyunsaturated fatty acids in cryptorchid rat testes. Biol. Reprod. 2007, 77:181-188.
40. Furland N.E., Oresti G.M., Antollini S.S., Venturino A., Maldonado E.N., Aveldano M.I. Very long-chain polyunsaturated fatty acids are the major acyl groups of sphingomyelins and ceramides in the head of mammalian spermatozoa. J. Biol. Chem. 2007, 282:18151-18161.
41. Furland N.E., Zanetti S.R., Oresti G.M., Maldonado E.N., Aveldano M.I. Ceramides and sphingomyelins with high proportions of very long-chain polyunsaturated fatty acids in mammalian germ cells. J. Biol. Chem. 2007, 282:18141-18150.
42. Gold B., Merriam J.E., Zernant J., Hancox L.S., Taiber A.J., Gehrs K., Cramer K., Neel J., Bergeron J., Barile G.R., Smith R.T., Hageman G.S., Dean M., Allikmets R. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 2006, 38:458-462.
43. Grayson C., Molday R.S. Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4. J. Biol. Chem. 2005, 280:32521-32530.
44. Griesinger I.B., Sieving P.A., Ayyagari R. Autosomal dominant macular atrophy at 6q14 excludes CORD7 and MCDR1/PBCRA loci. Invest. Ophthalmol. Vis. Sci. 2000, 41:248-255.
45. Haddad S., Chen C.A., Santangelo S.L., Seddon J.M. The genetics of age-related macular degeneration: a review of progress to date. Surv. Ophthalmol. 2006, 51:316-363.
46. Hadden O.B., Gass J.D. Fundus flavimaculatus and Stargardt's disease. Am. J. Ophthalmol. 1976, 82:527-539.
47. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J.R., Schnetz-Boutaud N., Agarwal A., Postel E.A., Pericak-Vance M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421.
48. Harding H.P., Calfon M., Urano F., Novoa I., Ron D. Transcriptional and translational control in the mammalian unfolded protein response. Annu. Rev. Cell Dev. Biol. 2002, 18:575-599.
49. Hauswirth W.W., LaVail M.M., Flannery J.G., Lewin A.S. Ribozyme gene therapy for autosomal dominant retinal disease. Clin. Chem. Lab. Med. 2000, 38:147-153.
50. Hoffmann M., Wagner M., Abbadi A., Fulda M., Feussner I. Metabolic engineering of omega3-very long chain polyunsaturated fatty acid production by an exclusively acyl-CoA-dependent pathway. J. Biol. Chem. 2008, 283:22352-22362.
51. Hubbard A.F., Askew E.W., Singh N., Leppert M., Bernstein P.S. Association of adipose and red blood cell lipids with severity of dominant Stargardt macular dystrophy (STGD3) secondary to an ELOVL4 mutation. Arch. Ophthalmol. 2006, 124:257-263.
52. Hyman L., Neborsky R. Risk factors for age-related macular degeneration: an update. Curr. Opin. Ophthalmol. 2002, 13:171-175.
53. Jeffrey B.G., Weisinger H.S., Neuringer M., Mitchell D.C. The role of docosahexaenoic acid in retinal function. Lipids 2001, 36:859-871.
54. Johnson L.V., Leitner W.P., Staples M.K., Anderson D.H. Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp. Eye Res. 2001, 73:887-896.
55. Johnston J.A., Ward C.L., Kopito R.R. Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 1998, 143:1883-1898.
56. Kaplan J., Bonneau D., Frezal J., Munnich A., Dufier J.L. Clinical and genetic heterogeneity in retinitis pigmentosa. Hum. Genet. 1990, 85:635-642.
57. Karan G., Yang Z., Zhang K. Expression of wild type and mutant ELOVL4 in cell culture: subcellular localization and cell viability. Mol. Vis. 2004, 10:248-253.
58. Karan, G., Yang, Z., Zhang, K., 2004b. Expression of wild type and mutant ELOVL4 in cell culture: subcellular localization and cell viability. In: Annual Meeting of American Society of Human Genetics Abstract 1766/B577.
59. Karan G., Lillo C., Yang Z., Cameron D.J., Locke K.G., Zhao Y., Thirumalaichary S., Li C., Birch D.G., Vollmer-Snarr H.R., Williams D.S., Zhang K. Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:4164-4169.
60. Karan G., Yang Z., Howes K., Zhao Y., Chen Y., Cameron D.J., Lin Y., Pearson E., Zhang K. Loss of ER retention and sequestration of the wild-type ELOVL4 by Stargardt disease dominant negative mutants. Mol. Vis. 2005, 11:657-664.
61. Katz B., Minke B. Drosophila photoreceptors and signaling mechanisms. Front. Cell. Neurosci. 2009, 3:2.
62. Klaver C.C., Wolfs R.C., Assink J.J., van Duijn C.M., Hofman A., de Jong P.T. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch. Ophthalmol. 1998, 116:1646-1651.
63. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
64. Klien B.A., Krill A.E. Fundus flavimaculatus. Clinical, functional and histopathologic observations. Am. J. Ophthalmol. 1967, 64:3-23.
65. Kopito R.R., Ron D. Conformational disease. Nat. Cell Biol. 2000, 2:E207-E209.
66. Lagali P.S., Liu J., Ambasudhan R., Kakuk L.E., Bernstein S.L., Seigel G.M., Wong P.W., Ayyagari R. Evolutionarily conserved ELOVL4 gene expression in the vertebrate retina. Invest. Ophthalmol. Vis. Sci. 2003, 44:2841-2850.
67. Lagali P.S., MacDonald I.M., Griesinger I.B., Chambers M.L., Ayyagari R., Wong P.W. Autosomal dominant Stargardt-like macular dystrophy segregating in a large Canadian family. Can. J. Ophthalmol. 2000, 35:315-324.
68. LaVail M.M., Yasumura D., Matthes M.T., Drenser K.A., Flannery J.G., Lewin A.S., Hauswirth W.W. Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:11488-11493.
69. Leibowitz H.M., Krueger D.E., Maunder L.R., Milton R.C., Kini M.M., Kahn H.A., Nickerson R.J., Pool J., Colton T.L., Ganley J.P., Loewenstein J.I., Dawber T.R. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv. Ophthalmol. 1980, 24:335-610.
70. Li W., Chen Y., Cameron D.J., Wang C., Karan G., Yang Z., Zhao Y., Pearson E., Chen H., Deng C., Howes K., Zhang K. Elovl4 haploinsufficiency does not induce early onset retinal degeneration in mice. Vision Res. 2007, 47:714-722.
71. Li W., Sandhoff R., Kono M., Zerfas P., Hoffmann V., Ding B.C., Proia R.L., Deng C.X. Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice. Int. J. Biol. Sci. 2007, 3:120-128.
72. Lopez P.F., Maumenee I.H., de la Cruz Z., Green W.R. Autosomal-dominant fundus flavimaculatus. Clinicopathologic correlation. Ophthalmology 1990, 97:798-809.
73. MacDonald I.M., Hebert M., Yau R.J., Flynn S., Jumpsen J., Suh M., Clandinin M.T. Effect of docosahexaenoic acid supplementation on retinal function in a patient with autosomal dominant Stargardt-like retinal dystrophy. Br. J. Ophthalmol. 2004, 88:305-306.
74. Mandal M.N., Ambasudhan R., Wong P.W., Gage P.J., Sieving P.A., Ayyagari R. Characterization of mouse orthologue of ELOVL4: genomic organization and spatial and temporal expression. Genomics 2004, 83:626-635.
75. Mansour A.M. Long-term follow-up of dominant macular dystrophy with flecks (Stargardt). Ophthalmologica 1992, 205:138-143.
76. Marmorstein A.D., Marmorstein L.Y. The challenge of modeling macular degeneration in mice. Trends Genet. 2007, 23:225-231.
77. Maugeri A., Meire F., Hoyng C.B., Vink C., Van Regemorter N., Karan G., Yang Z., Cremers F.P., Zhang K. A novel mutation in the ELOVL4 gene causes autosomal dominant Stargardt-like macular dystrophy. Invest. Ophthalmol. Vis. Sci. 2004, 45:4263-4267.
78. McMahon A., Kedzierski W. Polyunsaturated extremely long chain C28-C36 fatty acids and retinal physiology. Br. J. Ophthalmol. Aug 9, 2009, [Epub ahead of print].
79. McMahon A., Butovich I.A., Mata N.L., Klein M., Ritter R., Richardson J., Birch D.G., Edwards A.O., Kedzierski W. Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4. Mol. Vis. 2007, 13:258-272.
80. McMahon A., Jackson S.N., Woods A.S., Kedzierski W. A Stargardt disease-3 mutation in the mouse Elovl4 gene causes retinal deficiency of C32-C36 acyl phosphatidylcholines. FEBS Lett. 2007, 581:5459-5463.
81. Mears A.J., Kondo M., Swain P.K., Takada Y., Bush R.A., Saunders T.L., Sieving P.A., Swaroop A. Nrl is required for rod photoreceptor development. Nat. Genet. 2001, 29:447-452.
82. Meyers S.M. A twin study on age-related macular degeneration. Trans. Am. Ophthalmol. Soc. 1994, 92:775-843.
83. Motta S., Monti M., Sesana S., Mellesi L., Ghidoni R., Caputo R. Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch. Dermatol. 1994, 130:452-456.
84. Noble K.G., Carr R.E. Stargardt's disease and fundus flavimaculatus. Arch. Ophthalmol. 1979, 97:1281-1285.
85. Oda Y., Uchida Y., Moradian S., Crumrine D., Elias P.M., Bikle D.D. Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation. J. Invest. Dermatol. 2009, 129:1367-1378.
86. Oh C.S., Toke D.A., Mandala S., Martin C.E. ELO2 and ELO3, homologues of the Saccharomyces cerevisiae ELO1 gene, function in fatty acid elongation and are required for sphingolipid formation. J. Biol. Chem. 1997, 272:17376-17384.
87. Omura N., Li C.P., Li A., Hong S.M., Walter K., Jimeno A., Hidalgo M., Goggins M. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma. Cancer Biol. Ther. 2008, 7:1146-1156.
88. O'Shea J.G. Age-related macular degeneration: a leading cause of blindness. Med. J. Aust. 1996, 165:561-564.
89. Pahl H.L. Signal transduction from the endoplasmic reticulum to the cell nucleus. Physiol. Rev. 1999, 79:683-701.
90. Penfold P.L., Madigan M.C., Gillies M.C., Provis J.M. Immunological and aetiological aspects of macular degeneration. Prog. Retin. Eye Res. 2001, 20:385-414.
91. Pilgram G.S., Vissers D.C., van der Meulen H., Pavel S., Lavrijsen S.P., Bouwstra J.A., Koerten H.K. Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis. J. Invest. Dermatol. 2001, 117:710-717.
92. Proksch E., Brandner J.M., Jensen J.M. The skin: an indispensable barrier. Exp. Dermatol. 2008, 17:1063-1072.
93. Raz-Prag D., Ayyagari R., Fariss R.N., Mandal M.N., Vasireddy V., Majchrzak S., Webber A.L., Bush R.A., Salem N., Petrukhin K., Sieving P.A. Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease. Invest. Ophthalmol. Vis. Sci. 2006, 47:3603-3611.
94. Ross C.A., Poirier M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 2004, 10(Suppl.):S10-S17.
95. Sakaguchi H., Miyagi M., Shadrach K.G., Rayborn M.E., Crabb J.W., Hollyfield J.G. Clusterin is present in drusen in age-related macular degeneration. Exp. Eye Res. 2002, 74:547-549.
96. Saliba R.S., Munro P.M., Luthert P.J., Cheetham M.E. The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation. J. Cell. Sci. 2002, 115:2907-2918.
97. Seddon J.M., Cote J., Page W.F., Aggen S.H., Neale M.C. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch. Ophthalmol. 2005, 123:321-327.
98. Seddon J.M., Cote J., Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch. Ophthalmol. 2003, 121:1728-1737.
99. Seddon J.M., Cote J., Davis N., Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch. Ophthalmol. 2003, 121:785-792.
100. Seddon J.M., Rosner B., Sperduto R.D., Yannuzzi L., Haller J.A., Blair N.P., Willett W. Dietary fat and risk for advanced age-related macular degeneration. Arch. Ophthalmol. 2001, 119:1191-1199.
101. Seddon J.M., Willett W.C., Speizer F.E., Hankinson S.E. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996, 276:1141-1146.
102. Sprong H., van der Sluijs P., van Meer G. How proteins move lipids and lipids move proteins. Nat. Rev. Mol. Cell Biol. 2001, 2:504-513.
103. Stargardt K. Uber familiare, progressive degeneration in der Maculagegend des Auges. Albrecht von Graefes Arch. Klin. Ophthalmol. 1909, 71:534-550.
104. Starr C.E., Guyer D.R., Yannuzzi L.A. Age-related macular degeneration. Can we stem this worldwide public health crisis?. Postgrad. Med 1998, 103:153-156. 161-164.
105. Stone E.M., Nichols B.E., Kimura A.E., Weingeist T.A., Drack A., Sheffield V.C. Clinical features of a Stargardt-like dominant progressive macular dystrophy with genetic linkage to chromosome 6q. Arch. Ophthalmol. 1994, 112:765-772.
106. Swaroop A., Chew E.Y., Rickman C.B., Abecasis G.R. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu. Rev. Genomics Hum. Genet. 2009, 10:19-43.
107. Uchida Y., Holleran W.M. Omega-O-acylceramide, a lipid essential for mammalian survival. J. Dermatol. Sci. 2008, 51:77-87.
108. Umeda S., Suzuki M.T., Okamoto H., Ono F., Mizota A., Terao K., Yoshikawa Y., Tanaka Y., Iwata T. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). FASEB J. 2005, 19:1683-1685.
109. Vasireddy V., Jablonski M.M., Mandal M.N., Raz-Prag D., Wang X.F., Nizol L., Iannaccone A., Musch D.C., Bush R.A., Salem N., Sieving P.A., Ayyagari R. Elovl4 5-bp-deletion knock-in mice develop progressive photoreceptor degeneration. Invest. Ophthalmol. Vis. Sci. 2006, 47:4558-4568.
110. Vasireddy V., Sharon M., Salem N., Ayyagari R. Role of ELOVL4 in fatty acid metabolism. Adv. Exp. Med. Biol. 2008, 613:283-290.
111. Vasireddy V., Uchida Y., Salem N., Kim S.Y., Mandal M.N., Reddy G.B., Bodepudi R., Alderson N.L., Brown J.C., Hama H., Dlugosz A., Elias P.M., Holleran W.M., Ayyagari R. Loss of functional ELOVL4 depletes very long-chain fatty acids (> or = C28) and the unique omega-O-acylceramides in skin leading to neonatal death. Hum. Mol. Genet. 2007, 16:471-482.
112. Vasireddy V., Vijayasarathy C., Huang J., Wang X.F., Jablonski M.M., Petty H.R., Sieving P.A., Ayyagari R. Stargardt-like macular dystrophy protein ELOVL4 exerts a dominant negative effect by recruiting wild-type protein into aggresomes. Mol. Vis. 2005, 11:665-676.
113. Wakil S.J. Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 1989, 28:4523-4530.
114. Weng J., Mata N.L., Azarian S.M., Tzekov R.T., Birch D.G., Travis G.H. Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice. Cell 1999, 98:13-23.
115. Yates J.R., Sepp T., Matharu B.K., Khan J.C., Thurlby D.A., Shahid H., Clayton D.G., Hayward C., Morgan J., Wright A.F., Armbrecht A.M., Dhillon B., Deary I.J., Redmond E., Bird A.C., Moore A.T. Complement C3 variant and the risk of age-related macular degeneration. N. Engl. J. Med. 2007, 357:553-561.
116. Young R.W. Pathophysiology of age-related macular degeneration. Surv. Ophthalmol. 1987, 31:291-306.
117. Zhang K., Kniazeva M., Han M., Li W., Yu Z., Yang Z., Li Y., Metzker M.L., Allikmets R., Zack D.J., Kakuk L.E., Lagali P.S., Wong P.W., MacDonald I.M., Sieving P.A., Figueroa D.J., Austin C.P., Gould R.J., Ayyagari R., Petrukhin K. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat. Genet. 2001, 27:89-93.
118. Zhang Q., Mashima Y., Noda S., Imamura Y., Kudoh J., Shimizu N., Nishiyama T., Umeda S., Oguchi Y., Tanaka Y., Iwata T. Characterization of AOC2 gene encoding a copper-binding amine oxidase expressed specifically in retina. Gene 2003, 318:45-53.
119. Zimmermann T.S., Lee A.C., Akinc A., Bramlage B., Bumcrot D., Fedoruk M.N., Harborth J., Heyes J.A., Jeffs L.B., John M., et al. RNAi-mediated gene silencing in non-human primates. Nature 2006, 441:111-114.